416 related articles for article (PubMed ID: 34664753)
1. Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19.
Torres-Torres J; Espino-Y-Sosa S; Poon LC; Solis-Paredes JM; Estrada-Gutierrez G; Espejel-Nuñez A; Juarez-Reyes A; Etchegaray-Solana A; Alfonso-Guillen Y; Aguilar-Andrade L; Hernández-Pacheco JA; Villafan-Bernal JR; Martinez-Portilla RJ
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):202-208. PubMed ID: 34664753
[TBL] [Abstract][Full Text] [Related]
2. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
[TBL] [Abstract][Full Text] [Related]
3. Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19.
Espino-Y-Sosa S; Martinez-Portilla RJ; Torres-Torres J; Solis-Paredes JM; Estrada-Gutierrez G; Hernandez-Pacheco JA; Espejel-Nuñez A; Mateu-Rogell P; Juarez-Reyes A; Lopez-Ceh FE; Villafan-Bernal JR; Rojas-Zepeda L; Guzman-Guzman IP; Poon LC
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696336
[TBL] [Abstract][Full Text] [Related]
4. Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor.
Fiolna M; Machuca M; Karampitsakos T; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):604-608. PubMed ID: 31444934
[TBL] [Abstract][Full Text] [Related]
5. Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection.
Giardini V; Ornaghi S; Gambacorti-Passerini C; Casati M; Carrer A; Acampora E; Vasarri MV; Arienti F; Vergani P
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298762
[TBL] [Abstract][Full Text] [Related]
6. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
7. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
8. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
Shinohara S; Uchida Y; Kasai M; Sunami R
Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
[TBL] [Abstract][Full Text] [Related]
9. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
[TBL] [Abstract][Full Text] [Related]
10. sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19.
Soldavini CM; Di Martino D; Sabattini E; Ornaghi S; Sterpi V; Erra R; Invernizzi F; Tine' G; Giardini V; Vergani P; Ossola MW; Ferrazzi E
Pregnancy Hypertens; 2022 Mar; 27():103-109. PubMed ID: 34998223
[TBL] [Abstract][Full Text] [Related]
11. Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management.
Nobrega GM; Guida JP; Novaes JM; Solda LM; Pietro L; Luz AG; Lajos GJ; Ribeiro-do-Valle CC; Souza RT; Cecatti JG; Mysorekar IU; Dias TZ; Laura Costa M
Pregnancy Hypertens; 2023 Mar; 31():32-37. PubMed ID: 36525933
[TBL] [Abstract][Full Text] [Related]
12. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study.
Donati S; Corsi E; Maraschini A; Salvatore MA;
BJOG; 2022 Jan; 129(2):221-231. PubMed ID: 34687585
[TBL] [Abstract][Full Text] [Related]
14. Prediction of adverse maternal outcomes of early severe preeclampsia.
Mirkovic L; Tulic I; Stankovic S; Soldatovic I
Pregnancy Hypertens; 2020 Oct; 22():144-150. PubMed ID: 32979729
[TBL] [Abstract][Full Text] [Related]
15. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
Kumar N; Das V; Agarwal A; Agrawal S
AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
[TBL] [Abstract][Full Text] [Related]
17. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study.
Mendoza M; Garcia-Ruiz I; Maiz N; Rodo C; Garcia-Manau P; Serrano B; Lopez-Martinez RM; Balcells J; Fernandez-Hidalgo N; Carreras E; Suy A
BJOG; 2020 Oct; 127(11):1374-1380. PubMed ID: 32479682
[TBL] [Abstract][Full Text] [Related]
18. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
[TBL] [Abstract][Full Text] [Related]
19. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
20. sFlt-1/PlGF Ratio Is Not a Good Predictor of Severe COVID-19 nor of Adverse Outcome in Pregnant Women with SARS-CoV-2 Infection-A Case-Control Study.
Malicka E; Szymusik I; Rebizant B; Dąbrowski F; Brawura-Biskupski-Samaha R; Kosińska-Kaczyńska K
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
